SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-007732
Filing Date
2019-02-14
Accepted
2019-02-14 11:00:33
Documents
1
Group Members
DAN MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G tv513719_sc13g.htm SC 13G 51292
  Complete submission text file 0001144204-19-007732.txt   52884
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Subject) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88949 | Film No.: 19602598
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820
Business Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G